26 April 2024
Wilmington
plc
APM sold for €26
million
Wilmington plc (LSE: WIL,
'Wilmington', 'the Group'), the provider of data, information,
education and training in the global Governance, Risk and
Compliance markets, has sold its French healthcare business, APM,
for an enterprise value of €26 million in cash, subject to
customary working capital adjustments, to Philia Medical Editions
SAS, a subsidiary of Europa Group.
For the year ended 30 June 2023, APM
had gross assets of €9.6 million and reported a profit before tax
of €2.3 million. The proceeds of the sale will be used for general
corporate purposes.
Mark Milner, Chief Executive Officer
of Wilmington, said
"This sale reflects our continued
and active management of our portfolio as we assess the potential
of each business to exhibit the six common Wilmington
characteristics that we recognise as key drivers of organic revenue
growth and profitability improvement."
Marc Doncieux, Chairman and co-Founder
of Europa Group, said
"APM's entry into Europa Group is a
major asset in consolidating our position as the French leader in
training and health information. APM is a key player in our market,
whose reputation for excellence and independence is perfectly in
line with Europa Group's global strategy. We are delighted to
welcome them on board!"
For further information,
contact:
|
Wilmington plc
Mark Milner, Chief Executive
Officer
Guy Millward, Chief Financial
Officer
Meare Consulting
Adrian Duffield
|
020
7490 0049
07990 858548
|
Notes to Editors
Wilmington plc is the recognised
knowledge leader and partner of choice for data, information,
education and training in the global Governance, Risk and
Compliance (GRC) markets. Wilmington employs close to 1,000 people
and sells to around 120 countries. Wilmington is listed on the main
market of the London Stock Exchange